ACTIVE

PHARMACIE ERGO

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result22,2 k €-39,9 %over 1 year

Gross margin309,9 k €+0,8 %over 1 year

Equity832,7 k €+2,7 %over 1 year

Workforce2,7 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE ERGO is a Private company with limited liability incorporated in 2004. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Estinnes. It employs on average 2,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0869.621.727
Incorporation: 25/10/2004
Legal form: Private company with limited liability
Registered office: Rue Grande(EVL) 117
7120 Estinnes · WallonieSee on map
Contributed capital: 100 000,00 €
Latest accounts: 31/12/2025
Average workforce: 2,7 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	309,9 k €	+0.8%	307,5 k €	+6.0%	290 k €	+0.6%	288,3 k €	-19.0%	355,9 k €
EBITDA	119,8 k €	-20.9%	151,5 k €	+10.4%	137,3 k €	-8.7%	150,3 k €	-24.7%	199,6 k €
Operating result	42,2 k €	-38.7%	68,8 k €	+19.6%	57,5 k €	-22.3%	74 k €	-43.1%	130,1 k €
Net result	22,2 k €	-39.9%	36,9 k €	+46.7%	25,2 k €	-43.5%	44,5 k €	-47.5%	84,8 k €
Balance sheet
Equity	832,7 k €	+2.7%	810,5 k €	+4.8%	773,6 k €	+3.4%	748,5 k €	+6.3%	703,9 k €
Total assets	1,3 M €	+11.5%	1,1 M €	+7.5%	1 M €	-3.6%	1,1 M €	-1.3%	1,1 M €
Cash	51,5 k €	-10.0%	57,2 k €	-30.0%	81,7 k €	+40.5%	58,2 k €	-47.6%	110,9 k €
Debts	420 k €	+34.0%	313,3 k €	+15.4%	271,5 k €	-19.2%	336,1 k €	-14.7%	394,1 k €
Other
Workforce	2,7 ETP	0.0%	2,7 ETP	0.0%	2,7 ETP	0.0%	2,7 ETP	-12.9%	3,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 11 ended

Active mandates

Nicolas GEUDENS

Director · since 01 janvier 2022

Active

PHARMACIE ESTINNES

Director · since 01 janvier 2022 · 0769.504.265

Represented by Cécile SCIEUR

Active

Ended mandates

ALPHAR PARTNERS

Director · 0475.639.696

Represented by Peter VAN ELSLANDER

Ended

EVERAERT FREZIN & Cie

Mandate · 0871.535.201

Represented by Olivier FREZIN

Ended

Fabienne Ergo

Managing director

Ended

Fabienne ERGO

Manager

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/05/2026	17/06/2025	10/06/2024	09/06/2023	25/05/2022	17/08/2021
General meeting	23/04/2026	24/04/2025	25/04/2024	27/04/2023	28/04/2022	27/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/04/2026	25/05/2026	French	PDF
Abridged model	31/12/2024	24/04/2025	17/06/2025	French	PDF
Abridged model	31/12/2023	25/04/2024	10/06/2024	French	PDF
Abridged model	31/12/2022	27/04/2023	09/06/2023	French	PDF
Abridged model	31/12/2021	28/04/2022	25/05/2022	French	PDF
Abridged model	31/12/2020	27/04/2021	17/08/2021	French	PDF
Abridged model	31/12/2019	02/06/2020	27/08/2020	French	PDF
Abridged model	31/12/2018	02/06/2019	21/06/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	31/08/2018	French	PDF
Abridged model	31/12/2016	09/03/2017	13/07/2017	French	PDF
Abridged model	31/12/2015	13/04/2016	14/04/2016	French	PDF
Abridged model	31/12/2014	15/05/2015	22/05/2015	French	PDF
Abridged model	31/12/2013	30/06/2014	14/07/2014	French	PDF
Abridged model	31/12/2012	08/04/2013	16/04/2013	French	PDF
Abridged model	31/12/2011	16/02/2012	29/02/2012	French	PDF
Full model	31/12/2010	30/06/2011	19/07/2011	French	PDF
Full model	31/12/2009	19/03/2010	03/05/2010	French	PDF
Full model	31/12/2008	29/05/2009	13/07/2009	French	PDF
Full model	31/12/2007	23/06/2008	08/07/2008	French	PDF
Full model	31/12/2006	15/03/2007	27/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 11 ended

Active mandates

Nicolas GEUDENS

Director · since 01 janvier 2022

Active

PHARMACIE ESTINNES

Director · since 01 janvier 2022 · 0769.504.265

Represented by Cécile SCIEUR

Active

Ended mandates

ALPHAR PARTNERS

Director · 0475.639.696

Represented by Peter VAN ELSLANDER

Ended

EVERAERT FREZIN & Cie

Mandate · 0871.535.201

Represented by Olivier FREZIN

Ended

Fabienne Ergo

Managing director

Ended

Fabienne ERGO

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates20/01/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates30/04/2013
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Restructuring28/01/2013
DENOMINATION - OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring09/07/2012
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates13/12/2011
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates11/03/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates21/02/2006
DEMISSIONS, NOMINATIONS
PDF
Other04/11/2004
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202522,2 k €↓
2024
Annual accounts 202436,9 k €↑
2023
Annual accounts 202325,2 k €↓
2022
Annual accounts 202244,5 k €↓
2021
Annual accounts 202184,8 k €↓
2020
Annual accounts 202087,7 k €↑
2019
Annual accounts 201958,3 k €↑
2018
Annual accounts 201854,4 k €↑
2017
Annual accounts 201728,4 k €↓
2016
Annual accounts 201653,9 k €↑
2015
Annual accounts 201548 k €↑
2014
Annual accounts 201434,7 k €↑
2013
Annual accounts 201329,1 k €↓
2012
Annual accounts 201236,7 k €↓
2011
Annual accounts 201158,6 k €↑
2010
Annual accounts 201051,2 k €↑
2009
Annual accounts 200943,1 k €↑
2008
Annual accounts 200826,7 k €↑
2007
Annual accounts 200724,8 k €
25/10/2004
IncorporationPrivate company with limited liability

PHARMACIE ERGO

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline